163 related articles for article (PubMed ID: 6352490)
1. Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen.
Yeung MK; Mattingly SJ
Infect Immun; 1983 Oct; 42(1):141-51. PubMed ID: 6352490
[TBL] [Abstract][Full Text] [Related]
2. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci.
Yeung MK; Mattingly SJ
Infect Immun; 1984 May; 44(2):217-21. PubMed ID: 6370860
[TBL] [Abstract][Full Text] [Related]
3. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.
Wessels MR; Haft RF; Heggen LM; Rubens CE
Infect Immun; 1992 Feb; 60(2):392-400. PubMed ID: 1309720
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model.
Durham DL; Mattingly SJ; Doran TI; Milligan TW; Straus DC
Infect Immun; 1981 Nov; 34(2):448-54. PubMed ID: 7030959
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.
Shigeoka AO; Rote NS; Santos JI; Hill HR
J Infect Dis; 1983 May; 147(5):857-63. PubMed ID: 6341485
[TBL] [Abstract][Full Text] [Related]
6. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
Marques MB; Kasper DL; Pangburn MK; Wessels MR
Infect Immun; 1992 Oct; 60(10):3986-93. PubMed ID: 1398910
[TBL] [Abstract][Full Text] [Related]
7. Deletion of repeats in the alpha C protein enhances the pathogenicity of group B streptococci in immune mice.
Gravekamp C; Rosner B; Madoff LC
Infect Immun; 1998 Sep; 66(9):4347-54. PubMed ID: 9712787
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci.
Mancuso G; Tomasello F; von Hunolstein C; Orefici G; Teti G
Infect Immun; 1994 Jul; 62(7):2748-53. PubMed ID: 8005664
[TBL] [Abstract][Full Text] [Related]
9. Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).
Orefici G; Recchia S; Galante L
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):302-5. PubMed ID: 3134236
[TBL] [Abstract][Full Text] [Related]
10. Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
Wessels MR; Rubens CE; Benedí VJ; Kasper DL
Proc Natl Acad Sci U S A; 1989 Nov; 86(22):8983-7. PubMed ID: 2554337
[TBL] [Abstract][Full Text] [Related]
11. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).
von Hunolstein C; D'Ascenzi S; Wagner B; Jelínková J; Alfarone G; Recchia S; Wagner M; Orefici G
Infect Immun; 1993 Apr; 61(4):1272-80. PubMed ID: 8454331
[TBL] [Abstract][Full Text] [Related]
12. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes.
Johnson DR; Ferrieri P
J Clin Microbiol; 1984 Apr; 19(4):506-10. PubMed ID: 6201506
[TBL] [Abstract][Full Text] [Related]
13. Role of group B streptococcal capsular polysaccharides in the induction of septic arthritis.
Tissi L; von Hunolstein C; Bistoni F; Marangi M; Parisi L; Orefici G
J Med Microbiol; 1998 Aug; 47(8):717-23. PubMed ID: 9877193
[TBL] [Abstract][Full Text] [Related]
14. Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
Stålhammar-Carlemalm M; Stenberg L; Lindahl G
J Exp Med; 1993 Jun; 177(6):1593-603. PubMed ID: 8496678
[TBL] [Abstract][Full Text] [Related]
15. Growth of group B streptococci in human serum leads to increased cell surface sialic acid and decreased activation of the alternative complement pathway.
Platt MW; Correa N; Mold C
Can J Microbiol; 1994 Feb; 40(2):99-105. PubMed ID: 8019940
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of two Streptococcus suis capsular type 2 mutants.
Gottschalk M; Higgins R; Jacques M; Dubreuil D
Vet Microbiol; 1992 Jan; 30(1):59-71. PubMed ID: 1536064
[TBL] [Abstract][Full Text] [Related]
17. Influence of sialic contents on the chemiluminescent response of human leucocytes to group B streptococci.
De Paoli P; Mucignat C; Orefici G; Santini G
Microbiologica; 1985 Oct; 8(4):379-86. PubMed ID: 3906368
[TBL] [Abstract][Full Text] [Related]
18. Multiple polysaccharide antigens of group B streptococcus, type Ia: emphasis on a sialic acid type-specific polysaccharide.
Kane JA; Karakawa WW
J Immunol; 1977 Jun; 118(6):2155-60. PubMed ID: 68081
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of two group B streptococcal virulence factors.
Rubens CE; Wessels MR; Kuypers JM; Kasper DL; Weiser JN
Semin Perinatol; 1990 Aug; 14(4 Suppl 1):22-9. PubMed ID: 2173147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
